Detalhe da pesquisa
1.
Getting the MOST out of follow-up: a randomized controlled trial comparing 3 monthly nurse led follow-up via telehealth, including monitoring CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic based or telehealth follow-up, after completion of first line chemotherapy in patients with epithelial ovarian cancer.
Int J Gynecol Cancer
; 32(4): 560-565, 2022 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34551895